Results 101 to 110 of about 136,983,672 (229)

Phenotypic and genetically predicted sleep traits in relation to dementia incidence in Swedish twins

open access: yesAlzheimer's &Dementia, Volume 22, Issue 11, November 2026.
Abstract INTRODUCTION Sleep and dementia are complex phenotypes shaped by genetic and environmental factors, but the genetic contribution of sleep to dementia risk remains unclear. This study examined associations of both phenotypic and genetically predicted sleep traits and their interaction with dementia risk.
Manasa Shanta Näsholm   +3 more
wiley   +1 more source

Stapled truncated orexin peptides as orexin receptor agonists

open access: yesPeptides, 2018
The peptides orexin-A and -B, the endogenous agonists of the orexin receptors, have similar 19-amino-acid C-termini which retain full maximum response as truncated peptides with only marginally reduced potency, while further N-terminal truncations successively reduce the activity.
Karhu, L   +7 more
openaire   +5 more sources

Requirement of intact disulfide bonds in orexin-A-induced stimulation of gastric acid secretion that is mediated by OX1 receptor activation [PDF]

open access: yes, 2001
authorOrexin-A is a neuropeptide consisting 33 amino acids with two intrachain disulfide bonds, namely Cys6-Cys12 and Cys7-Cys14, and is a potent stimulator of food consumption and gastric acid secretion.
オクムラ, トシカツ   +10 more
core   +1 more source

Orexinergic descending modulation of pain and itch

open access: yesFrontiers in Neuroscience
Descending pain control dynamically regulates nociceptive transmission through brainstem and spinal circuits according to behavioral and physiological demands.
Hideki Kashiwadani   +2 more
doaj   +1 more source

Differential Roles of Each Orexin Receptor Signaling in Obesity

open access: yesiScience, 2019
Summary: Orexins are hypothalamic neuropeptides that regulate feeding, energy expenditure, and sleep. Although orexin-deficient mice are susceptible to obesity, little is known about the roles of the orexin receptors in long-term energy metabolism. Here,
Miyo Kakizaki   +9 more
doaj   +1 more source

Efficacy of High‐Frequency Transcranial Magnetic Stimulation Therapy for Depression With Insomnia Symptoms: A Systematic Review and Meta‐Analysis Based on Randomized Controlled Trials

open access: yesBrain and Behavior, Volume 16, Issue 11, November 2026.
It summarizes the key findings: improves sleep quality (SMD0.97) and depressive symptoms(SMD0.61) in depression‐related insomia ABSTRACT Background This meta‐analysis evaluated the efficacy of high‐frequency repetitive transcranial magnetic stimulation (HF‐rTMS) targeting the left dorsolateral prefrontal cortex (DLPFC) in patients with comorbid ...
Wenqing Yang   +5 more
wiley   +1 more source

Global Prevalence of Clinically Significant Insomnia Among Cancer Patients: A Systematic Review and Meta‐Analysis

open access: yesBrain and Behavior, Volume 16, Issue 11, November 2026.
This is a meta‐analysis of 39 studies comprising 14,094 cancer patients across 16 countries. The pooled global prevalence was 34.6% (95% CI: 27.2–44.1). Subgroup analyses revealed a higher prevalence in high‐income countries compared to low‐income countries. Meta‐regression showed that smaller sample size was associated with higher prevalence estimates.
Ting Du, Linyu Luo, Langli Gao, Juan Lv
wiley   +1 more source

Differential roles of orexin receptors in the regulation of sleep/wakefulness

open access: yesFrontiers in Endocrinology, 2013
Orexin A and orexin B are hypothalamic neuropeptides that play critical roles in the regulation of sleep/wakefulness, as well as in a variety of physiological functions such as emotion, reward, and energy homeostasis.
Michihiro eMieda   +2 more
doaj   +1 more source

Advances in Multidimensional Molecular Mechanisms of Epilepsy and Precision Therapy Strategies

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 11, November 2026.
Epilepsy arises from a multidimensional network imbalance, integrating genetic, inflammatory, and metabolic disruptions. This complexity drives neuronal hyperexcitability and underpins therapeutic challenges. Our review highlights how emerging precision strategies, from targeted molecular therapies to neuromodulation, offer a transformative path toward
Yimin Han   +7 more
wiley   +1 more source

Clinical applications of wearable devices for individuals with at‐risk substance use and substance use disorders: A systematic review

open access: yesThe American Journal on Addictions, Volume 35, Issue 6, Page 702-726, November 2026.
Abstract Background and Objectives Managing substance use disorders (SUDs) is limited by the lack of longitudinal clinical data during active use and recovery. Wearable devices may help address this gap by capturing physiological and behavioral data in real‐world settings.
Alexandra Sas   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy